BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11923062)

  • 1. Fast dispersible ibuprofen tablets.
    Schiermeier S; Schmidt PC
    Eur J Pharm Sci; 2002 Apr; 15(3):295-305. PubMed ID: 11923062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics.
    Yasmin R; Shoaib MH; Ahmed FR; Qazi F; Ali H; Zafar F
    PLoS One; 2020; 15(2):e0223201. PubMed ID: 32050259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Milky Way: paediatric milk-based dispersible tablets prepared by direct compression - a proof-of-concept study.
    Orubu SE; Hobson NJ; Basit AW; Tuleu C
    J Pharm Pharmacol; 2017 Apr; 69(4):417-431. PubMed ID: 27349946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-step Coprocessing of Cohesive Powder via Mechanical Dry Coating for Direct Tablet Compression.
    Qu L; Stewart PJ; Hapgood KP; Lakio S; Morton DAV; Zhou QT
    J Pharm Sci; 2017 Jan; 106(1):159-167. PubMed ID: 27665128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocimum Sanctum seeds, a natural superdisintegrant: formulation and evaluation of fast melt tablets of nimesulide.
    Malik K; Arora G; Singh I
    Polim Med; 2012; 42(1):49-59. PubMed ID: 22783733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
    Patel N; Madan P; Lin S
    Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets.
    Shimizu T; Sugaya M; Nakano Y; Izutsu D; Mizukami Y; Okochi K; Tabata T; Hamaguchi N; Igari Y
    Chem Pharm Bull (Tokyo); 2003 Oct; 51(10):1121-7. PubMed ID: 14519914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
    Kokott M; Lura A; Breitkreutz J; Wiedey R
    Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
    Labib GS
    Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast dispersible/slow releasing ibuprofen tablets.
    Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
    Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the tableting behavior of Ibuprofen DC 85 W.
    Al-Karawi C; Cech T; Bang F; Leopold CS
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1262-1272. PubMed ID: 29499616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping.
    Buck J; Huwyler J; Kühl P; Dischinger A
    Pharm Res; 2016 Aug; 33(8):2043-55. PubMed ID: 27251416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro determination of aceclofenac Mouth Dissolving Tablets.
    Shobhit S; Gupta SK
    Polim Med; 2013; 43(4):227-9. PubMed ID: 24596037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
    Dille MJ; Hattrem MN; Draget KI
    Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants.
    Goel H; Tiwary AK; Rana V
    Acta Pol Pharm; 2011; 68(4):571-83. PubMed ID: 21796940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability.
    Bowles BJ; Dziemidowicz K; Lopez FL; Orlu M; Tuleu C; Edwards AJ; Ernest TB
    AAPS PharmSciTech; 2018 Aug; 19(6):2598-2609. PubMed ID: 29916193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.